September 27, 2011
Teva Pharmaceutical Industries of Israel announced on September 26 that it would resolve its joint venture with Kowa Co., Ltd as of September 27. Teva will acquire the 50% interest formerly held by Kowa in the 50:50 joint venture company...read more